REIT - Office
Compare Stocks
3 / 10Stock Comparison
ARE vs CTRE vs IIPR
Revenue, margins, valuation, and 5-year total return — side by side.
REIT - Healthcare Facilities
REIT - Industrial
ARE vs CTRE vs IIPR — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||
|---|---|---|---|
| Industry | REIT - Office | REIT - Healthcare Facilities | REIT - Industrial |
| Market Cap | $7.89B | $8.82B | $1.62B |
| Revenue (TTM) | $2.90B | $468M | $263M |
| Net Income (TTM) | $-1.02B | $335M | $120M |
| Gross Margin | 68.2% | 86.8% | 60.3% |
| Operating Margin | -42.8% | 69.1% | 46.7% |
| Forward P/E | 78.8x | 26.6x | 13.2x |
| Total Debt | $12.76B | $894M | $394M |
| Cash & Equiv. | $549M | $198M | $48M |
ARE vs CTRE vs IIPR — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Alexandria Real Est… (ARE) | 100 | 29.7 | -70.3% |
| CareTrust REIT, Inc. (CTRE) | 100 | 212.1 | +112.1% |
| Innovative Industri… (IIPR) | 100 | 69.3 | -30.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: ARE vs CTRE vs IIPR
Each card shows where this stock fits in a portfolio — not just who wins on paper.
ARE plays a supporting role in this comparison — it may shine differently against other peers.
CTRE carries the broadest edge in this set and is the clearest fit for growth exposure and sleep-well-at-night.
- Rev growth 108.8%, EPS growth 96.3%, 3Y rev CAGR 36.5%
- Lower volatility, beta 0.14, Low D/E 22.1%, current ratio 1.54x
- PEG 1.25 vs IIPR's 3.52
IIPR is the clearest fit if your priority is income & stability and long-term compounding.
- Dividend streak 9 yrs, beta 0.92, yield 13.5%
- 436.4% 10Y total return vs CTRE's 265.1%
- 13.5% yield, 9-year raise streak, vs ARE's 11.7%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 108.8% FFO/revenue growth vs IIPR's -13.8% | |
| Value | Lower P/E (26.6x vs 78.8x) | |
| Quality / Margins | 71.5% margin vs ARE's -35.3% | |
| Stability / Safety | Beta 0.14 vs ARE's 0.95, lower leverage | |
| Dividends | 13.5% yield, 9-year raise streak, vs ARE's 11.7% | |
| Momentum (1Y) | +40.3% vs ARE's -30.9% | |
| Efficiency (ROA) | 6.7% ROA vs ARE's -2.9%, ROIC 6.1% vs -2.7% |
ARE vs CTRE vs IIPR — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
ARE vs CTRE vs IIPR — Financial Metrics
Side-by-side numbers across 3 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
CTRE leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ARE is the larger business by revenue, generating $2.9B annually — 11.0x IIPR's $263M. CTRE is the more profitable business, keeping 71.5% of every revenue dollar as net income compared to ARE's -35.3%. On growth, CTRE holds the edge at +99.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||
|---|---|---|---|
| RevenueTrailing 12 months | $2.9B | $468M | $263M |
| EBITDAEarnings before interest/tax | $74M | $428M | $197M |
| Net IncomeAfter-tax profit | -$1.0B | $335M | $120M |
| Free Cash FlowCash after capex | $1.4B | $400M | $144M |
| Gross MarginGross profit ÷ Revenue | +68.2% | +86.8% | +60.3% |
| Operating MarginEBIT ÷ Revenue | -42.8% | +69.1% | +46.7% |
| Net MarginNet income ÷ Revenue | -35.3% | +71.5% | +45.6% |
| FCF MarginFCF ÷ Revenue | +48.4% | +85.5% | +54.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | -9.7% | +99.3% | -3.8% |
| EPS Growth (YoY)Latest quarter vs prior year | +31.9% | +2.9% | -1.0% |
Valuation Metrics
ARE leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 14.4x trailing earnings, IIPR trades at a 43% valuation discount to CTRE's 25.2x P/E. Adjusting for growth (PEG ratio), CTRE offers better value at 1.19x vs IIPR's 3.85x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||
|---|---|---|---|
| Market CapShares × price | $7.9B | $8.8B | $1.6B |
| Enterprise ValueMkt cap + debt − cash | $20.1B | $9.5B | $2.0B |
| Trailing P/EPrice ÷ TTM EPS | -5.40x | 25.17x | 14.40x |
| Forward P/EPrice ÷ next-FY EPS est. | 78.79x | 26.58x | 13.17x |
| PEG RatioP/E ÷ EPS growth rate | — | 1.19x | 3.85x |
| EV / EBITDAEnterprise value multiple | 135.65x | 23.03x | 9.91x |
| Price / SalesMarket cap ÷ Revenue | 2.66x | 18.51x | 6.08x |
| Price / BookPrice ÷ Book value/share | 0.41x | 2.00x | 0.87x |
| Price / FCFMarket cap ÷ FCF | 5.58x | 23.27x | 9.26x |
Profitability & Efficiency
CTRE leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
CTRE delivers a 8.6% return on equity — every $100 of shareholder capital generates $9 in annual profit, vs $-5 for ARE. IIPR carries lower financial leverage with a 0.21x debt-to-equity ratio, signaling a more conservative balance sheet compared to ARE's 0.67x. On the Piotroski fundamental quality scale (0–9), ARE scores 5/9 vs IIPR's 4/9, reflecting solid financial health.
| Metric | |||
|---|---|---|---|
| ROE (TTM)Return on equity | -5.0% | +8.6% | +6.4% |
| ROA (TTM)Return on assets | -2.9% | +6.7% | +5.1% |
| ROICReturn on invested capital | -2.7% | +6.1% | +4.3% |
| ROCEReturn on capital employed | -3.6% | +7.7% | +5.8% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 5 | 4 |
| Debt / EquityFinancial leverage | 0.67x | 0.22x | 0.21x |
| Net DebtTotal debt minus cash | $12.2B | $696M | $346M |
| Cash & Equiv.Liquid assets | $549M | $198M | $48M |
| Total DebtShort + long-term debt | $12.8B | $894M | $394M |
| Interest CoverageEBIT ÷ Interest expense | -4.37x | 8.44x | 6.67x |
Total Returns (Dividends Reinvested)
CTRE leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CTRE five years ago would be worth $19,660 today (with dividends reinvested), compared to $3,887 for ARE. Over the past 12 months, CTRE leads with a +40.3% total return vs ARE's -30.9%. The 3-year compound annual growth rate (CAGR) favors CTRE at 29.6% vs ARE's -21.2% — a key indicator of consistent wealth creation.
| Metric | |||
|---|---|---|---|
| YTD ReturnYear-to-date | -5.5% | +9.9% | +18.3% |
| 1-Year ReturnPast 12 months | -30.9% | +40.3% | +20.3% |
| 3-Year ReturnCumulative with dividends | -51.0% | +117.8% | +14.1% |
| 5-Year ReturnCumulative with dividends | -61.1% | +96.6% | -50.0% |
| 10-Year ReturnCumulative with dividends | -8.6% | +265.1% | +436.4% |
| CAGR (3Y)Annualised 3-year return | -21.2% | +29.6% | +4.5% |
Risk & Volatility
CTRE leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
CTRE is the less volatile stock with a 0.14 beta — it tends to amplify market swings less than ARE's 0.95 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CTRE currently trades 94.7% from its 52-week high vs ARE's 51.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||
|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.95x | 0.14x | 0.92x |
| 52-Week HighHighest price in past year | $88.24 | $41.72 | $61.40 |
| 52-Week LowLowest price in past year | $39.41 | $27.72 | $44.58 |
| % of 52W HighCurrent price vs 52-week peak | +51.7% | +94.7% | +92.2% |
| RSI (14)Momentum oscillator 0–100 | 52.2 | 54.5 | 59.3 |
| Avg Volume (50D)Average daily shares traded | 2.5M | 2.5M | 303K |
Analyst Outlook
Evenly matched — ARE and IIPR each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: ARE as "Hold", CTRE as "Buy", IIPR as "Hold". Consensus price targets imply 20.7% upside for ARE (target: $55) vs -22.3% for IIPR (target: $44). For income investors, IIPR offers the higher dividend yield at 13.46% vs CTRE's 3.22%.
| Metric | |||
|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Hold |
| Price TargetConsensus 12-month target | $55.00 | $42.50 | $44.00 |
| # AnalystsCovering analysts | 24 | 19 | 11 |
| Dividend YieldAnnual dividend ÷ price | +11.7% | +3.2% | +13.5% |
| Dividend StreakConsecutive years of raises | 15 | 2 | 9 |
| Dividend / ShareAnnual DPS | $5.35 | $1.27 | $7.62 |
| Buyback YieldShare repurchases ÷ mkt cap | +2.6% | +0.0% | +1.2% |
CTRE leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). ARE leads in 1 (Valuation Metrics). 1 tied.
ARE vs CTRE vs IIPR: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is ARE or CTRE or IIPR a better buy right now?
For growth investors, CareTrust REIT, Inc.
(CTRE) is the stronger pick with 108. 8% revenue growth year-over-year, versus -13. 8% for Innovative Industrial Properties, Inc. (IIPR). Innovative Industrial Properties, Inc. (IIPR) offers the better valuation at 14. 4x trailing P/E (13. 2x forward), making it the more compelling value choice. Analysts rate CareTrust REIT, Inc. (CTRE) a "Buy" — based on 19 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — ARE or CTRE or IIPR?
On trailing P/E, Innovative Industrial Properties, Inc.
(IIPR) is the cheapest at 14. 4x versus CareTrust REIT, Inc. at 25. 2x. On forward P/E, Innovative Industrial Properties, Inc. is actually cheaper at 13. 2x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: CareTrust REIT, Inc. wins at 1. 25x versus Innovative Industrial Properties, Inc. 's 3. 52x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — ARE or CTRE or IIPR?
Over the past 5 years, CareTrust REIT, Inc.
(CTRE) delivered a total return of +96. 6%, compared to -61. 1% for Alexandria Real Estate Equities, Inc. (ARE). Over 10 years, the gap is even starker: IIPR returned +436. 4% versus ARE's -8. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — ARE or CTRE or IIPR?
By beta (market sensitivity over 5 years), CareTrust REIT, Inc.
(CTRE) is the lower-risk stock at 0. 14β versus Alexandria Real Estate Equities, Inc. 's 0. 95β — meaning ARE is approximately 595% more volatile than CTRE relative to the S&P 500. On balance sheet safety, Innovative Industrial Properties, Inc. (IIPR) carries a lower debt/equity ratio of 21% versus 67% for Alexandria Real Estate Equities, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — ARE or CTRE or IIPR?
By revenue growth (latest reported year), CareTrust REIT, Inc.
(CTRE) is pulling ahead at 108. 8% versus -13. 8% for Innovative Industrial Properties, Inc. (IIPR). On earnings-per-share growth, the picture is similar: CareTrust REIT, Inc. grew EPS 96. 3% year-over-year, compared to -568. 9% for Alexandria Real Estate Equities, Inc.. Over a 3-year CAGR, CTRE leads at 36. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — ARE or CTRE or IIPR?
CareTrust REIT, Inc.
(CTRE) is the more profitable company, earning 67. 3% net margin versus -48. 2% for Alexandria Real Estate Equities, Inc. — meaning it keeps 67. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CTRE leads at 67. 2% versus -40. 5% for ARE. At the gross margin level — before operating expenses — IIPR leads at 88. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is ARE or CTRE or IIPR more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, CareTrust REIT, Inc. (CTRE) is the more undervalued stock at a PEG of 1. 25x versus Innovative Industrial Properties, Inc. 's 3. 52x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Innovative Industrial Properties, Inc. (IIPR) trades at 13. 2x forward P/E versus 78. 8x for Alexandria Real Estate Equities, Inc. — 65. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ARE: 20. 7% to $55. 00.
08Which pays a better dividend — ARE or CTRE or IIPR?
All stocks in this comparison pay dividends.
Innovative Industrial Properties, Inc. (IIPR) offers the highest yield at 13. 5%, versus 3. 2% for CareTrust REIT, Inc. (CTRE).
09Is ARE or CTRE or IIPR better for a retirement portfolio?
For long-horizon retirement investors, CareTrust REIT, Inc.
(CTRE) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 14), 3. 2% yield, +265. 1% 10Y return). Both have compounded well over 10 years (CTRE: +265. 1%, ARE: -8. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between ARE and CTRE and IIPR?
Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: ARE is a small-cap income-oriented stock; CTRE is a small-cap high-growth stock; IIPR is a small-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.